James J Schutz Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James J Schutz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James J Schutz. James J Schutz is in Sonoma Pharmaceuticals, Inc. ($OCLS) and Chief Executive Officer in Oculus Innovative Sciences, Inc. ($OCLS) and Chief Operating Officer in Oculus Innovative Sciences, Inc. ($OCLS) and Vice President in Oculus Innovative Sciences, Inc. ($OCLS).
Latest Insider Trading Transactions of James J Schutz
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 2.41 | 67,733 | 163,237 | 0 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 7.06 | 30,000 | 211,800 | 67,733 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 4.81 | 50,000 | 240,500 | 97,733 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 30.00 | 20,000 | 600,000 | 147,733 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 32.55 | 4,285 | 139,477 | 167,733 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 43.75 | 5,357 | 234,369 | 172,018 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 56.00 | 1,428 | 79,968 | 177,375 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 70.35 | 3,928 | 276,335 | 178,803 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 68.95 | 1,785 | 123,076 | 182,731 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 66.85 | 3,571 | 238,721 | 184,516 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Option Exercise | H | 38.15 | 5,271 | 201,089 | 188,087 | ||
Jul 24 2018 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Option Exercise | A | 2.41 | 67,733 | 163,237 | 193,358 | |
Mar 08 2018 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 3.99 | 2,473 | 9,867 | 35,858 | 33.4 K to 35.9 K (+7.41 %) |
Jan 03 2018 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Grant | A | 0.00 | 17,211 | 0 | 33,385 | 16.2 K to 33.4 K (+106.41 %) |
Dec 04 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 4.95 | 345 | 1,708 | 16,174 | 15.8 K to 16.2 K (+2.18 %) |
Nov 29 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 5.03 | 400 | 2,012 | 15,829 | 15.4 K to 15.8 K (+2.59 %) |
Nov 27 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 5.05 | 254 | 1,283 | 15,429 | 15.2 K to 15.4 K (+1.67 %) |
Aug 10 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 5.46 | 929 | 5,069 | 15,175 | 14.2 K to 15.2 K (+6.52 %) |
Jun 30 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Grant | A | 0.00 | 2,406 | 0 | 14,246 | 11.8 K to 14.2 K (+20.32 %) |
Apr 05 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Option Exercise | A | 7.06 | 30,000 | 211,800 | 133,658 | |
Mar 07 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 6.75 | 104 | 702 | 11,840 | 11.7 K to 11.8 K (+0.89 %) |
Mar 07 2017 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 6.78 | 696 | 4,719 | 11,736 | 11 K to 11.7 K (+6.30 %) |
Dec 08 2016 | OCLS | Sonoma Pharmaceuti ... | Schutz James J | Chief Executive Off ... | Buy | P | 4.88 | 1,000 | 4,880 | 11,040 | 10 K to 11 K (+9.96 %) |
Dec 02 2016 | OCLS | Oculus Innovative ... | Schutz James J | Chief Executive Off ... | Option Exercise | A | 4.81 | 50,000 | 240,500 | 103,658 | |
Dec 02 2016 | OCLS | Oculus Innovative ... | Schutz James J | Chief Executive Off ... | Grant | A | 4.81 | 3,535 | 17,003 | 10,040 | 6.5 K to 10 K (+54.34 %) |
Aug 16 2016 | OCLS | Oculus Innovative ... | Schutz James J | Chief Executive Off ... | Buy | P | 3.66 | 1,328 | 4,866 | 6,505 | 5.2 K to 6.5 K (+25.65 %) |
Feb 29 2016 | OCLS | Oculus Innovative ... | Schutz James J | Chief Executive Off ... | Buy | P | 1.00 | 5,000 | 5,000 | 25,885 | 20.9 K to 25.9 K (+23.94 %) |
Nov 17 2014 | OCLS | Oculus Innovative ... | Schutz James J | Chief Executive Off ... | Buy | P | 1.78 | 6,285 | 11,187 | 20,885 | 14.6 K to 20.9 K (+43.05 %) |
Sep 20 2013 | OCLS | Oculus Innovative ... | Schutz James J | Chief Executive Off ... | Option Exercise | A | 6.00 | 100,000 | 600,000 | 232,298 | |
Aug 19 2013 | OCLS | Oculus Innovative ... | Schutz James J | Chief Executive Off ... | Buy | P | 2.35 | 5,100 | 11,985 | 14,600 | 9.5 K to 14.6 K (+53.68 %) |
Nov 09 2012 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Buy | P | 0.78 | 1,000 | 780 | 66,500 | 65.5 K to 66.5 K (+1.53 %) |
Nov 09 2012 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Buy | P | 0.80 | 500 | 400 | 65,500 | 65 K to 65.5 K (+0.77 %) |
Nov 09 2012 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Buy | P | 0.80 | 11,400 | 9,120 | 65,000 | 53.6 K to 65 K (+21.27 %) |
Nov 09 2012 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Buy | P | 0.80 | 100 | 80 | 53,600 | 53.5 K to 53.6 K (+0.19 %) |
Aug 27 2012 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Option Exercise | A | 0.93 | 150,000 | 139,500 | 1,147,000 | |
Mar 09 2012 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Option Exercise | A | 1.25 | 187,500 | 234,375 | 997,000 | |
Jun 17 2011 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Option Exercise | A | 1.60 | 50,000 | 80,000 | 809,500 | |
Apr 01 2011 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Option Exercise | A | 2.01 | 137,500 | 276,375 | 759,500 | |
Aug 09 2010 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Buy | P | 1.91 | 11,680 | 22,309 | 53,500 | 41.8 K to 53.5 K (+27.93 %) |
Aug 09 2010 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Buy | P | 1.85 | 6,820 | 12,617 | 41,820 | 35 K to 41.8 K (+19.49 %) |
Jun 09 2010 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Option Exercise | A | 1.97 | 62,500 | 123,125 | 622,000 | |
Dec 09 2009 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Buy | P | 1.76 | 1,890 | 3,326 | 35,000 | 33.1 K to 35 K (+5.71 %) |
Dec 09 2009 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Buy | P | 1.77 | 3,490 | 6,177 | 33,110 | 29.6 K to 33.1 K (+11.78 %) |
Dec 09 2009 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Buy | P | 1.79 | 20 | 36 | 29,620 | 29.6 K to 29.6 K (+0.07 %) |
Dec 09 2009 | OCLS | Oculus Innovative ... | Schutz James J | Chief Operating Off ... | Buy | P | 1.80 | 14,600 | 26,280 | 29,600 | 15 K to 29.6 K (+97.33 %) |
Aug 13 2009 | OCLS | Oculus Innovative ... | Schutz James J | Vice President | Buy | P | 2.05 | 3,300 | 6,765 | 15,000 | 11.7 K to 15 K (+28.21 %) |
Aug 13 2009 | OCLS | Oculus Innovative ... | Schutz James J | Vice President | Buy | P | 2.04 | 500 | 1,020 | 11,700 | 11.2 K to 11.7 K (+4.46 %) |
Aug 13 2009 | OCLS | Oculus Innovative ... | Schutz James J | Vice President | Buy | P | 2.02 | 700 | 1,414 | 11,200 | 10.5 K to 11.2 K (+6.67 %) |
Aug 13 2009 | OCLS | Oculus Innovative ... | Schutz James J | Vice President | Buy | P | 2.00 | 500 | 1,000 | 10,500 | 10 K to 10.5 K (+5.00 %) |
Dec 07 2007 | OCLS | Oculus Innovative ... | Schutz James J | Vice President | Buy | P | 4.59 | 3,250 | 14,918 | 0 | -3,250 to 0 (-100.00 %) |
Dec 07 2007 | OCLS | Oculus Innovative ... | Schutz James J | Vice President | Buy | P | 4.67 | 6,750 | 31,523 | 0 | -6,750 to 0 (-100.00 %) |
Page: 1